New Products and New Indications

Stay up-to-date on FDA approved products now available through ASD Healthcare.

Pharmaceutical products on shelves

Oncology

New indication

Darazlex Faspro®

New indication FDA approved: 1.15.21

New indication

Libtayo®

New indication FDA approved: 2.22.21

New indication 

Opdivo®

New indication FDA approved: 1.21.21

New indication

Xalkori®

New indication FDA approved: 1.14.21

Specialty Pharmaceuticals

New product

FluMist®

ASD Healthcare launch date: 10.27.20

New product

Monoferric®

ASD Healthcare launch date: 10.12.20
Live Chat
Click to Start
Offline